The effects of hypoestrogenism on the vaginal wall: Interference with the normal sexual response

Journal of Sexual Medicine

Volumn 6, Issue 1, 2009, Pages 30-39

  da Silva Lara, Lucia Alves ^a,c   Useche, Bernardo ^b   Ferriani, Rui Alberto ^a   Reis, Rosana Maria ^a   De Sá, Marcos Felipe Silva ^a   De Freitas, Mauricio Mesquita Sabino ^a   E Silva, Julio César Rosa ^a   De Sá Rosa E Silva, Ana Carolina Japur ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF TEXAS   (United States)

^c NONE   (Brazil)

Author keywords

Dyspareunia; Estrogen; Female Sexual Function; Menopause; Sexual Arousal; Vaginal Wall

Indexed keywords

ESTRADIOL; ESTRIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; G ACTIN; PROMESTRIENE; SILDENAFIL;

CELL CONTACT; CELL JUNCTION; CELL STRUCTURE; DYSPAREUNIA; ESTROGEN ACTIVITY; ESTROGEN DEFICIENCY; ESTROGEN THERAPY; GENE EXPRESSION; HORMONE SUBSTITUTION; HUMAN; HYPOESTROGENISM; LAMINA PROPRIA; LOADING DRUG DOSE; LUBRICATION; MASTALGIA; PRIORITY JOURNAL; REVIEW; SEXUAL AROUSAL DISORDER; SEXUAL FUNCTION; SMOOTH MUSCLE FIBER; VAGINA ATROPHY; VAGINA BLEEDING; VAGINA EPITHELIUM; VAGINA WALL; VAGINAL DRYNESS; VAGINAL LUBRICATION; VASODILATATION;

EID: 58149482042     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2008.01052.x     Document Type: Review

References (105)

1. Suh DD, Yang CC, Cao Y, Garland PA, Maravilla KR. Magnetic resonance imaging anatomy of the female genitalia in premenopausal and postmenopausal women. J Urol 2003;170:138-44.
2. Brauer M, Laan E, Ter Kuile MM. Sexual arousal in Women with Superficial Dyspareunia. Arch Sex Behav 2006;20:20.
3. Basson R, Berman J, Burnett A, Derogatis L, Ferguson D, Fourcroy J, Goldstein I, Graziottin A, Heiman J, Laan E, Leiblum S, Padma-Nathan H, Rosen R, Segraves K, Segraves RT, Shabsigh R, Sipski M, Wagner G, Whipple B. Report of the international consensus development conference on female sexual dysfunction: Definitions and classifications. J Urol 2000;163:888-93.
4. Arcos B. Female sexual function and response. J Am Osteopath Assoc 2004;104:S16-20.
5. Alzate H, Hoch Z. The "G spot"and "female ejaculation": A current appraisal. J Sex Marital Ther 1986;12:211-20.
6. Hoch Z. Vaginal erotic sensitivity by sexological examination. Acta Obstet Gynecol Scand 1986;65:767-73.
7. Useche B. El examen sexológico en las disfunciones excitatorias y orgásmicas femeninas. [The sexological exam in the excitatory and orgasmic female dysfunctions.] Revista Terapia Sexual 2001;4:115-31.
8. D'Amati G, di Gioia CR, Proietti Pannunzi L, Pistilli D, Carosa E, Lenzi A, Jannini EA. Functional anatomy of the human vagina. J Endocrinol Invest 2003;26:92-6.
9. Both S, Spiering M, Laan E, Belcome S, van den Heuvel B, Everaerd W. Unconscious classical conditioning of sexual arousal: Evidence for the conditioning of female genital arousal to subliminally presented sexual stimuli. J Sex Med 2008;5:100-9.
10. Basson R, Althof S, Davis S, Fugl-Meyer K, Goldstein I, Leiblum S, Meston C, Rosen R, Wagner G. Summary of the recommendations on sexual dysfunctions in women. J Sex Med 2004;1:24-34.
11. Levin RJ. VIP, vagina, clitoral and periurethral glans-an update on human female genital arousal. Exp Clin Endocrinol 1991;98:61-9.
12. Munarriz R, Kim NN, Goldstein I, Traish AM. Biology of female sexual function. Urol Clin North Am 2002;29:685-93.
13. Min K, O'Connell L, Munarriz R, Huang YH, Choi S, Kim N, Goldstein I, Traish A. Experimental models for the investigation of female sexual function and dysfunction. Int J Impot Res 2001;13:151-6.
14. Bredkjoer HE, Palle C, Ekblad E, Fahrenkrug J, Ottesen B. PreproVIP-derived peptides in the human female genital tract: Expression and biological function. Neuropeptides 1997;31:209-15.
15. Basson R. The complexities of female sexual arousal disorder: Potential role of pharmacotherapy. World J Urol 2002;20:119-26.
16. Leiblum SR. Arousal disorders in women: Complaints and complexities. Med J Aust 2003;178:638-40.
17. Bachmann GA, Leiblum SR. The impact of hormones on menopausal sexuality: A literature review. Menopause 2004;11:120-30.
18. Basson R. Hormones and sexuality: Current complexities and future directions. Maturitas 2007;57:66-70.
19. Berman JR, McCarthy MM, Kyprianou N. Effect of estrogen withdrawal on nitric oxide synthase expression and apoptosis in the rat vagina. Urology 1998;51:650-6.
20. Cayan F, Dilek U, Pata O, Dilek S. Comparison of the effects of hormone therapy regimens, oral and vaginal estradiol, estradiol + drospirenone and tibolone, on sexual function in healthy postmenopausal women. J Sex Med 2008;5:132-8.
21. Hsu Y, Chen L, Delancey JO, Ashton-Miller JA. Vaginal thickness, cross-sectional area, and perimeter in women with and those without prolapse. Obstet Gynecol 2005;105:1012-7.
22. O'Connell HE, Eizenberg N, Rahman M, Cleeve J. The anatomy of the distal vagina: Towards unity. J Sex Med 2008;17:17.
23. Pessina MA, Hoyt RF Jr, Goldstein I, Traish AM. Differential regulation of the expression of estrogen, progesterone, and androgen receptors by sex steroid hormones in the vagina: Immunohistochemical studies. J Sex Med 2006;3:804-14.
24. Fu X, Rezapour M, Wu X, Li L, Sjogren C, Ulmsten U. Expression of estrogen receptor-alpha and -beta in anterior vaginal walls of genuine stress incontinent women. Int Urogynecol J Pelvic Floor Dysfunct 2003;14:276-81. discussion 81.
25. Dahlman-Wright K, Cavailles V, Fuqua SA, Jordan VC, Katzenellenbogen JA, Korach KS, Maggi A, Muramatsu M, Parker MG, Gustafsson JA. International union of pharmacology. LXIV. Estrogen receptors. Pharmacol Rev 2006;58:773-81.
26. Hodgins MB, Spike RC, Mackie RM, MacLean AB. An immunohistochemical study of androgen, oestrogen and progesterone receptors in the vulva and vagina. Br J Obstet Gynaecol 1998;105:216-22.
27. Blakeman PJ, Hilton P, Bulmer JN. Oestrogen and progesterone receptor expression in the female lower urinary tract, with reference to oestrogen status. BJU Int 2000;86:32-8.
28. Chen Z, Yuhanna IS, Galcheva-Gargova Z, Karas RH, Mendelsohn ME, Shaul PW. Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest 1999;103:401-6.
29. Gebhart JB, Rickard DJ, Barrett TJ, Lesnick TG, Webb MJ, Podratz KC, Spelsberg TC. Expression of estrogen receptor isoforms alpha and beta messenger RNA in vaginal tissue of premenopausal and postmenopausal women. Am J Obstet Gynecol 2001;185:1325-30. discussion 30-1.
30. Pessina MA, Hoyt RF Jr, Goldstein I, Traish AM. Differential effects of estradiol, progesterone, and testosterone on vaginal structural integrity. Endocrinology 2006;147:61-9.
31. Lotocki W. Neurotrophic basis of atrophic changes in the vagina and vulva. Przegl Lek 1999;56:81-5.
32. Hilliges M, Falconer C, Ekman-Ordeberg G, Johansson O. Innervation of the human vaginal mucosa as revealed by PGP 9.5 immunohistochemistry. Acta Anat 1995;153:119-26.
33. Shafik A, Shafik AA, Sibai OE, Shafik IA. Identification of a vaginal pacemaker: An immunohistochemical and morphometric study. J Obstet Gynaecol 2007;27:485-8.
34. Shafik A, El Sibai O, Shafik AA, Ahmed I, Mostafa RM. The electrovaginogram: Study of the vaginal electric activity and its role in the sexual act and disorders. Arch Gynecol Obstet 2004;269:282-6.
35. Gravina GL, Brandetti F, Martini P, Carosa E, Di Stasi SM, Morano S, Lenzi A, Jannini EA. Measurement of the thickness of the urethrovaginal space in women with or without vaginal orgasm. J Sex Med 2008;5:610-8.
36. Söderberg MW, Johansson B, Masironi B, Byström B, Falconer C, Sahlin L, Ordeberg GE. Pelvic floor sex steroid hormone receptors, distribution and expression in pre- and postmenopausal stress urinary incontinent women. Acta Obstet Gynecol Scand 2007;86:1377-84.
37. Bochicchio B, Pepe A, Tamburro AM. Investigating by CD the molecular mechanism of elasticity of elastomeric proteins. Chirality 2008;21:21.
38. Farhat MY, Lavigne MC, Ramwell PW. The vascular protective effects of estrogen. Faseb J 1996;10:615-24.
39. Mendelsohn ME. Genomic and nongenomic effects of estrogen in the vasculature. Am J Cardiol 2002;90:3F-6F.
40. Veille JC, Li P, Eisenach JC, Massmann AG, Figueroa JP. Effects of estrogen on nitric oxide biosynthesis and vasorelaxant activity in sheep uterine and renal arteries in vitro. Am J Obstet Gynecol 1996;174:1043-9.
41. Ottesen B, Pedersen B, Nielsen J, Dalgaard D, Wagner G, Fahrenkrug J. Vasoactive intestinal polypeptide (VIP) provokes vaginal lubrication in normal women. Peptides 1987;8:797-800.
42. Alatas E, Yagci B, Oztekin O, Sabir N. Effect of hormone replacement therapy on clitoral artery blood flow in healthy postmenopausal women. J Sex Med 2008;10:10.
43. Cotreau MM, Chennathukuzhi VM, Harris HA, Han L, Dorner AJ, Apseloff G, Varadarajan U, Hatstat E, Zakaria M, Strahs AL, Crabtree JS, Winneker RC, Jelinsky SA. A study of 17beta-estradiol-regulated genes in the vagina of postmenopausal women with vaginal atrophy. Maturitas 2007;8:8.
44. North American Menopause Society. Estrogen and progestogen use in peri- and postmenopausal women: March 2007 position statement of The North American Menopause Society. Menopause 2007;14:168-82.
45. Gannon BJ, Warnes GM, Carati CJ, Verco CJ. Aquaporin-1 expression in visceral smooth muscle cells of female rat reproductive tract. J Smooth Muscle Res 2000;36:155-67.
46. Park K, Han HJ, Kim SW, Jung SI, Kim SO, Lee HS, Lee MN, Ahn K. Expression of aquaporin water channels in rat vagina: Potential role in vaginal lubrication. J Sex Med 2008;5:77-82.
47. Gupta S, Kumar N, Singhal N, Manektala U, Jain S, Sodhani P. Cytohormonal and morphological alterations in cervicovaginal smears of postmenopausal women on hormone replacement therapy. Diagn Cytopathol 2006;34:676-81.
48. Foster DC, Palmer M, Marks J. Effect of vulvovaginal estrogen on sensorimotor response of the lower genital tract: A randomized controlled trial. Obstet Gynecol 1999;94:232-7.
49. Nilsson K, Risberg B, Heimer G. The vaginal epithelium in the postmenopause-cytology, histology and pH as methods of assessment. Maturitas 1995;21:51-6.
50. Bachmann G. Urogenital ageing: An old problem newly recognized. Maturitas 1995;22(suppl):S1-5.
51. Edwall L, Carlstrom K, Jonasson AF. Markers of collagen synthesis and degradation in urogenital tissue from women with and without stress urinary incontinence. Neurourol Urodyn 2005;24:319-24.
52. Soderberg MW, Falconer C, Bystrom B, Malmstrom A, Ekman G. Young women with genital prolapse have a low collagen concentration. Acta Obstet Gynecol Scand 2004;83:1193-8.
53. Gorodeski GI. Aging and estrogen effects on transcervical-transvaginal epithelial permeability. J Clin Endocrinol Metab 2005;90:345-51.
54. Wen Y, Zhao YY, Li S, Polan ML, Chen BH. Differences in mRNA and protein expression of small proteoglycans in vaginal wall tissue from women with and without stress urinary incontinence. Hum Reprod 2007;22:1718-24.
55. Resplande J, Gholami SS, Graziottin TM, Rogers R, Lin CS, Leng W, Lue TF. Long-term effect of ovariectomy and simulated birth trauma on the lower urinary tract of female rats. J Urol 2002;168:323-30.
56. Ting AY, Blacklock AD, Smith PG. Estrogen regulates vaginal sensory and autonomic nerve density in the rat. Biol Reprod 2004;71:1397-404.
57. Kim NN, Min K, Pessina MA, Munarriz R, Goldstein I, Traish AM. Effects of ovariectomy and steroid hormones on vaginal smooth muscle contractility. Int J Impot Res 2004;16:43-50.
58. Levin RJ, Wylie K. Vaginal vasomotion-its appearance, measurement, and usefulness in assessing the mechanisms of vasodilatation. J Sex Med 2008;5:377-86.
59. Giraldi A, Marson L, Nappi R, Pfaus J, Traish AM, Vardi Y, Goldstein I. Physiology of female sexual function: Animal models. J Sex Med 2004;1:237-53.
60. Verit FF, Yeni E, Kafali H. Progress in female sexual dysfunction. Urol Int 2006;76:1-10.
61. Stevenson BR, Keon BH. The tight junction: Morphology to molecules. Annu Rev Cell Dev Biol 1998;14:89-109.
62. FitzGerald MP, Russell B, Hale D, Benson JT, Brubaker L. Ultrastructure of detrusor and urethral smooth muscle in women with urinary incontinence. Am J Obstet Gynecol 2000;182:879-84.
63. Gorodeski GI. Vaginal-cervical epithelial permeability decreases after menopause. Fertil Steril 2001;76:753-61.
64. Georgiadis JR, Kortekaas R, Kuipers R, Nieuwenburg A, Pruim J, Reinders AA, Holstege G. Regional cerebral blood flow changes associated with clitorally induced orgasm in healthy women. Eur J Neurosci 2006;24:3305-16.
65. Garcia S, Talakoub L, Maitland S, Dennis A, Goldstein I, Munarriz R. Genital duplex Doppler ultrasonography before and after sexual stimulation in women with sexual dysfunction: Gray scale, volumetric, and hemodynamic findings. Fertil Steril 2005;83:995-9.
66. Gianotten WL, te Velde ER. The influence of sexual function on the chance of pregnancy. Ned Tijdschr Geneeskd 2005;149:1207-10.
67. Tang LJ, De Seta F, Odreman F, Venge P, Piva C, Guaschino S, Garcia RC. Proteomic analysis of human cervical-vaginal fluids. J Proteome Res 2007;6:2874-83.
68. Goldstein I, Berman JR. Vasculogenic female sexual dysfunction: Vaginal engorgement and clitoral erectile insufficiency syndromes. Int J Impot Res 1998;10(2suppl):S84-90. discussion S8-101.
69. Weijmar Schultz W, Basson R, Binik Y, Eschenbach D, Wesselmann U, Van Lankveld J. Women's sexual pain and its management. J Sex Med 2005;2:301-16.
70. MacNeill C. Dyspareunia. Obstet Gynecol Clin North Am 2006;33:565-77, viii.
71. Bradshaw HB, Berkley KJ. Estrogen replacement reverses ovariectomy-induced vaginal hyperalgesia in the rat. Maturitas 2002;41:157-65.
72. Foster DC, Hasday JD. Elevated tissue levels of interleukin-1 beta and tumor necrosis factor-alpha in vulvar vestibulitis. Obstet Gynecol 1997;89:291-6.
73. Greenstein A, Ben-Aroya Z, Fass O, Militscher I, Roslik Y, Chen J, Abramov L. Vulvar vestibulitis syndrome and estrogen dose of oral contraceptive pills. J Sex Med 2007;4:1679-83.
74. Brauer M, ter Kuile MM, Janssen SA, Laan E. The effect of pain-related fear on sexual arousal in women with superficial dyspareunia. Eur J Pain 2007;11:788-98.
75. Nathorst-Boos J, von Schoultz B, Carlstrom K. Elective ovarian removal and estrogen replacement therapy-Effects on sexual life, psychological well-being and androgen status. J Psychosom Obstet Gynaecol 1993;14:283-93.
76. Nicolosi A, Laumann EO, Glasser DB, Moreira ED Jr, Paik A, Gingell C. Sexual behavior and sexual dysfunctions after age 40: The global study of sexual attitudes and behaviors. Urology 2004;64:991-7.
77. Laan E, van Lunsen RH, Everaerd W. The effects of tibolone on vaginal blood flow, sexual desire and arousability in postmenopausal women. Climacteric 2001;4:28-41.
78. van Lunsen RH, Laan E. Genital vascular responsiveness and sexual feelings in midlife women: Psychophysiologic, brain, and genital imaging studies. Menopause 2004;11:741-8.
79. Dennerstein L, Lehert P, Burger H. The relative effects of hormones and relationship factors on sexual function of women through the natural menopausal transition. Fertil Steril 2005;84:174-80.
80. Barlow DH, Samsioe G, van Geelen JM. A study of European womens' experience of the problems of urogenital ageing and its management. Maturitas 1997;27:239-47.
81. Castelo-Branco C, Cancelo MJ, Villero J, Nohales F, Julia MD. Management of post-menopausal vaginal atrophy and atrophic vaginitis. Maturitas 2005;52(1suppl):S46-52.
82. Barentsen R, van de Weijer PH, Schram JH. Continuous low dose estradiol released from a vaginal ring versus estriol vaginal cream for urogenital atrophy. Eur J Obstet Gynecol Reprod Biol 1997;71:73-80.
83. Galhardo CL, Soares JM Jr, Simoes RS, Haidar MA, Rodrigues de Lima G, Baracat EC. Estrogen effects on the vaginal pH, flora and cytology in late postmenopause after a long period without hormone therapy. Clin Exp Obstet Gynecol 2006;33:85-9.
84. Ayton RA, Darling GM, Murkies AL, Farrell EA, Weisberg E, Selinus I, Fraser ID. A comparative study of safety and efficacy of continuous low dose oestradiol released from a vaginal ring compared with conjugated equine oestrogen vaginal cream in the treatment of postmenopausal urogenital atrophy. Br J Obstet Gynaecol 1996;103:351-8.
85. Suckling JA, Kennedy R, Lethaby A, Roberts H. Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst Rev 2006;4:CD001500.
86. Manonai J, Theppisai U, Suthutvoravut S, Udomsubpayakul U, Chittacharoen A. The effect of estradiol vaginal tablet and conjugated estrogen cream on urogenital symptoms in postmenopausal women: A comparative study. J Obstet Gynaecol Res 2001;27:255-60.
87. Dugal R, Hesla K, Sordal T, Aase KH, Lilleeidet O, Wickstrom E. Comparison of usefulness of estradiol vaginal tablets and estriol vagitories for treatment of vaginal atrophy. Acta Obstet Gynecol Scand 2000;79:293-7.
88. Tourgeman DE, Slater CC, Stanczyk FZ, Paulson RJ. Endocrine and clinical effects of micronized estradiol administered vaginally or orally. Fertil Steril 2001;75:200-2.
89. Goldstein I, Alexander JL. Practical aspects in the management of vaginal atrophy and sexual dysfunction in perimenopausal and postmenopausal women. J Sex Med 2005;2(3suppl):154-65.
90. Henriksson L, Stjernquist M, Boquist L, Alander U, Selinus I. A comparative multicenter study of the effects of continuous low-dose estradiol released from a new vaginal ring versus estriol vaginal pessaries in postmenopausal women with symptoms and signs of urogenital atrophy. Am J Obstet Gynecol 1994;171:624-32.
91. Nappi RE, Ferdeghini F, Sampaolo P, Vaccaro P, De Leonardis C, Albani F, Salonia A, Polatti F. Clitoral circulation in postmenopausal women with sexual dysfunction: A pilot randomized study with hormone therapy. Maturitas 2006;55:288-95.
92. Nijland EA, Weijmar Schultz WC, Nathorst-Boös J, Helmond FA, Van Lunsen RH, Palacios S, Norman RJ, Mulder RJ, Davis SR ; LISA study investigators. Tibolone and transdermal E2/NETA for the treatment of female sexual dysfunction in naturally menopausal women: Results of a randomized active-controlled trial. J Sex Med 2008;5:646-56.
93. Wolff JP, Cachelou R, Gueritee N. Absence of systemic hormonal effects in an oestradiol diether topically active on the vaginal mucosa. Maturitas 1982;4:239-46.
94. Caruso S, Intelisano G, Lupo L, Agnello C. Premenopausal women affected by sexual arousal disorder treated with sildenafil: A double-blind, cross-over, placebo-controlled study. BJOG 2001;108:623-8.
95. Uckert S, Ellinghaus P, Albrecht K, Jonas U, Oelke M. Expression of messenger ribonucleic acid encoding for phosphodiesterase isoenzymes in human female genital tissues. J Sex Med 2007;4:1604-9.
96. Weisberg E, Ayton R, Darling G, Farrell E, Murkies A, O'Neill S, Kirkegard Y, Fraser IS. Endometrial and vaginal effects of low-dose estradiol delivered by vaginal ring or vaginal tablet. Climacteric 2005;8:83-92.
97. Nachtigall LE. Comparative study: Replens versus local estrogen in menopausal women. Fertil Steril 1994;61:178-80.
98. Kenemans P. Postmenopausal hormone therapy and breast cancer: What is the problem? Maturitas 2005;51:75-82.
99. Leiblum S, Bachmann G, Kemmann E, Colburn D, Swartzman L. Vaginal atrophy in the postmenopausal woman. The importance of sexual activity and hormones. JAMA 1983;249:2195-8.
100. Franke HR, Brood-van Zanten MM, Burger CW, van der Mooren MJ, Kenemans P. Breast cancer and climacteric complaints: Weighing up risks of hormone therapy against quality of life. Eur J Obstet Gynecol Reprod Biol 2007;134:143-6.
101. Society of Obstetricians and Gynaecologists of Canada. SOGC clinical practice guidelines. The detection and management of vaginal atrophy. Number 145, May 2004. Int J Gynaecol Obstet 2005;88:222-8.
102. North American Menopause Society. The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society. Menopause 2007;14:355-69; quiz 70-1.
103. Dessole S, Rubattu G, Ambrosini G, Gallo O, Capobianco G, Cherchi PL, Marci R, Cosmi E. Efficacy of low-dose intravaginal estriol on urogenital aging in postmenopausal women. Menopause 2004;11:49-56.
104. Bachmann GA. The clinical platform for the 17beta-estradiol vaginal releasing ring. Am J Obstet Gynecol 1998;178:S257-60.
105. Schwenkhagen A. Hormonal changes in menopause and implications on sexual health. J Sex Med 2007;4(3suppl):220-6.